Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Autoimmunity and viruses.

Arndt Vogel1, Michael P Manns, Christian P Strassburg

  • 1Department of Gastroenterology, Hepatology and Endocrinology, Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, D-30623, Hannover, Germany.

Clinics in Liver Disease
|October 5, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durvalumab Plus Chemotherapy for Advanced Biliary Tract Cancer: A Post Hoc Analysis of the TOPAZ-1 Randomized Clinical Trial.

JAMA oncology·2026
Same author

Durvalumab with gemcitabine-based chemotherapy regimens in advanced biliary tract cancer: primary results from the phase IIIb TOURMALINE study.

Journal of hepatology·2026
Same author

A Serum lncRNA Signature Determines Oncogenic YAP Activity in Cancer Patients.

International journal of cancer·2026
Same author

Trends in the incidence and surgical treatment of hepatocellular carcinoma in Ontario.

Canadian journal of surgery. Journal canadien de chirurgie·2026
Same author

Nivolumab in combination with lenvatinib in unresectable hepatocellular carcinoma: The IKF-t006/IMMUNIB translational phase-2 study.

European journal of cancer (Oxford, England : 1990)·2026
Same author

Trial design and end points in hepatocellular carcinoma: an EASL-AASLD-ILCA consensus statement.

Nature reviews. Clinical oncology·2026

Viruses may trigger autoimmune diseases through molecular mimicry, where viral and host antigens are similar, causing immune system damage. Further research is needed to identify specific targets and mechanisms in autoimmune disease initiation.

Area of Science:

  • Immunology
  • Virology
  • Autoimmunity

Background:

  • Viruses are frequently implicated as triggers for autoimmune diseases.
  • The precise mechanisms by which viruses initiate autoimmunity remain largely unknown.
  • Molecular mimicry is a leading hypothesis, suggesting shared antigen similarities between viruses and self-tissues.

Purpose of the Study:

  • To explore the mechanisms by which viruses may initiate autoimmune responses.
  • To discuss the role of molecular mimicry, bystander effects, and superantigens in autoimmunity.
  • To highlight the need for further research differentiating pathogenic targets in autoimmune diseases.

Main Methods:

  • Review and synthesis of current hypotheses and proposed mechanisms.
  • Discussion of molecular mimicry, including epitope involvement (linear and conformational).

Related Experiment Videos

  • Consideration of bystander activation and superantigen effects on T cells (CD4 and CD8).

    • Main Results:

    • Viral antigens may initiate autoimmunity via molecular mimicry, where similarities with host antigens provoke an immune response.
    • Cross-reacting immune responses can be humoral, cellular, or both.
    • Bystander effects and superantigens can amplify autoimmune processes by exposing cryptic antigens or causing polyclonal T cell activation.

    Conclusions:

    • Understanding viral initiation of autoimmunity requires differentiating between self-antigens and non-self-antigens.
    • Further investigation using transgenic animal models is crucial to assess the pathogenicity of specific antigenic targets in autoimmune hepatitis (AIH) and other autoimmune conditions.